Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

Foxa1 decreases FA uptake. by Marta Moya (188959)

AICAR-activated AMPK decreased SREBP-2 protein levels. by Shudong Liu (733425)

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

DOM assembly monitored with temperature and pH reveals that, as either pH decreases or temperature increases, microgel equilibrium size and assembly rates decrease at a non-linear... by Chi-Shuo Chen (234719)

Loss of FOXP1 results in decreased number of bRGCs. by Seon Hye E. Park (16765033)

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

“…Points represent means and error bars represent standard errors. …”

Prolonged Htr2b activation decreases ATP content and coupled mitochondrial respiration in MIN6. by Luis Rodrigo Cataldo (3701206)

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

Ce6 decreases the amount of TMV PQS5 upon photo-irradiation. by Congbao Xie (17599247)

Comparison of mean differences in temperature decreases. by Hans-Jörg Gillmann (8460585)

Resveratrol decreases CYP17A1 and CYP21A2 protein expression. by Nesa Marti (3851059)

“…<p>A. Gene expression profiling by qRT-PCR was performed for CYP17, CYP21 and their cofactor POR in H295R cells grown under normal conditions (GM), starvation conditions (SM), metformin (Met) (1mM) treatment and under resveratrol (RSV) (5<u>μM)</u> treatment. …”

Rat LIPC sera decreased ROS in H₂O₂-injured HUVECs. by Min Chen (147733)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt^WT]/+</i> (filled black circles) and <i>+/-;P[syt^P-L]/+</i> (filled red circles) larvae at Ca²⁺ levels ranging from 0.05 mM—5.0 mM. …”

The G357S mutation decreases both activation and termination thresholds for SOICR. by Yingjie Liu (317210)

MeHg Exposure Makes O-2A/OPCs More Oxidized, Suppresses BrdU Incorporation, and Decreases Cell Division in Clonal Assays by Zaibo Li (273729)

“…Cultures were then stained with A2B5 and anti-BrdU antibodies (to recognize all progenitors and those synthesizing DNA during the BrdU pulse, respectively). …”

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

“…Myopic progression was significantly lower in group 1 (-0.43 +/- 0.19 D) than in group 2 (-1.24 +/- 0.37 D) and axial length increase was also significantly smaller in group 1(0.19 +/- 0.09 mm) than in group 2 (0.48 +/- 0.12 mm). …”

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)